Advertisement

Quality of Life of Patients with an Atrial Defibrillator: Does Optimal Programming Achieve the Goal of Maintaining Sinus Rhythm as Well as Improve Quality of Life?

  • A. Quesada
  • V. Palanca
  • J. Jimenez
  • O. Villalba
  • R. Paya
  • J.R. Balaguer
  • S. Illalba
  • J. Roda

Keywords

Atrial Fibrillation Irrational Belief Ventricular Pace Atrial Tachycardia Atrial Tachyarrhythmia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Dorian P, Jung W, Newman D et al (2000) The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol 36:1303–1309PubMedCrossRefGoogle Scholar
  2. 2.
    Luderitz B, Jung W (2000) Quality of life in atrial fibrillation. J Interv Card Electrophysiol 4:201–209PubMedCrossRefGoogle Scholar
  3. 3.
    Engelmann DE, Pehrson S (2003) Quality of life in nonpharmacologic treatment of atrial fibrillation. Eur Heart J 15:1387–1400CrossRefGoogle Scholar
  4. 4.
    Newman DM, Dorian P, Paquette M et al for Worldwide Jewel AF AF-Only Investigators (2003) Effect of an implantable cardioverter defibrillator with atrial detection and shock therapies on patient-perceived, health-related quality of life. Am Heart J 145:841–846PubMedCrossRefGoogle Scholar
  5. 5.
    Ricci R, Quesada A, Pignalberi C et al (2004) Dual defibrillator improves quality of life and decreases hospitalizations in patients with drug refractory atrial fibrillation. J Interv Card Electrophysiol 10:85–92PubMedCrossRefGoogle Scholar
  6. 6.
    Burns JL, Sears SF, Sotile R et al (2004) Do patients accept implantable atrial defibrillation therapy? Results from the Patient Atrial Shock Survey of Acceptance and Tolerance (PASSAT) Study. J Cardiovasc Electrophysiol 15:292–294CrossRefGoogle Scholar
  7. 7.
    Sweeney MO, Hellkamp AS, Ellenbogen KA et al for MOde Selection Trial Investigators (2003) Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 107:2932–2937PubMedCrossRefGoogle Scholar
  8. 8.
    Sweeney M, Shea J, Fox V et al (2004) Randomized pilot study of a new atrial-based minimal ventricular pacing mode in dual-chamber implantable cardioverter-defibrillators. Heart Rhythm 1:160–167PubMedCrossRefGoogle Scholar
  9. 9.
    Quesada A on behalf of AF investigators (2002) Dual defibrillator in patients with atrial fibrillation: clinical outcomes, quality of life and resource utilization. Mediterr J Pacing Electrophysiol 4:186–191Google Scholar
  10. 10.
    Carlson M, Ip J, Messenger J (2003) A new pacemaker algorithm for the treatment of atrial fibrillation: results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT). J Am Coll Cardiol 42:627–633PubMedCrossRefGoogle Scholar
  11. 11.
    Gold M, Fain E, Ip J et al (2004) Frequent ventricular pacing attenuates the benefit of dynamic atrial overdrive for the prevention of atrial fibrillation. NASPE, Heart Rhythm Society 2004, San Francisco, CAGoogle Scholar
  12. 12.
    Schoels W, Swerdlow CD, Jung W et al for the Worldwide Jewel AF Investigators (2001) Worldwide clinical experience with a new dual chamber implantable cardioverter defibrillator system. J Cardiovasc Electrophysiol 12:521–528PubMedCrossRefGoogle Scholar
  13. 13.
    Gold MR, Sulke N, Schwartzman DS et al for the Worldwide Jewel AF-only Investigators (2001) Clinical experience with a dual chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias. J Cardiovasc Electrophysiol 12:1247–1253PubMedCrossRefGoogle Scholar
  14. 14.
    Gillis A, Unterberg-Buchwald C, Schmidinger G et al for the GEM III AT worldwide investigators (2002) Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator. J Am Coll Cardiol 40:1653–1659PubMedCrossRefGoogle Scholar
  15. 15.
    Wellens HJJ, Lau CP, Luderitz B et al (1998) Atrioverter: an implantable device for the treatment of atrial fibrillation. Circulation 98:1651–1656PubMedGoogle Scholar
  16. 16.
    Swerdlow CD, Schwartzman D, Hoyt R et al for the Worldwide Model 7250 AF-Only Investigators (2002) Determinants of first-shock success for atrial implantable cardioverter defibrillators. J Cardiovasc Electrophysiol 13:347–354PubMedCrossRefGoogle Scholar
  17. 17.
    Mitchell AR, Spurrell PA, Kamalvand K et al (2002) What is the optimal electrode configuration for atrial defibrillators in man? Europace 4:41–46PubMedCrossRefGoogle Scholar
  18. 18.
    Boodhoo L, Mitchell A, Ujhelyi M et al (2004) Improving the acceptability of the atrial defibrillator: patient-activated cardioversion versus automatic night cardioversion with and without sedation (ADSAS 2). Pacing Clin Electrophysiol 27:910–917PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2005

Authors and Affiliations

  • A. Quesada
    • 1
  • V. Palanca
    • 1
  • J. Jimenez
    • 1
  • O. Villalba
    • 1
  • R. Paya
    • 1
  • J.R. Balaguer
    • 1
  • S. Illalba
    • 1
  • J. Roda
    • 1
  1. 1.Cardiac Electrophysiology and Arrhythmias Section, Department of CardiologyHospital General Universitario de ValenciaSpain

Personalised recommendations